SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

S26 - Neuro-opthalmology/Neuro-otology

Event Time: Tuesday April 25, 2017 3:30 pm to 5:30 pm
Topic(s): Neuro-ophthalmology/Neuro-otology
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
5:10 PM - 5:30 PM Discussion Gregory Van Stavern MD, FAAN 

Disclosures

Speaker Disclosure
Gregory P. Van Stavern, MD, FAAN Dr. Van Stavern has nothing to disclose.

Abstract Presenters

Start Time Pub. Title Presenter
3:30 PM 001 Overdiagnosis of optic neuritis. Leanne Stunkel, MD
Disclosure:
Dr. Stunkel has nothing to disclose.

3:42 PM 002 Sensory prosthetics - clinical and scientific utility of a vestibular implant Csilla Haburcakova
Disclosure:
Dr. Haburcakova has nothing to disclose.

3:54 PM 003 Ischemic Optic Neuropathy in Cardiac Surgery: Incidence and Risk Factors in the United States from the Nationwide Inpatient Sample 1998-2013 Heather Moss, MD, PhD, FAAN
Disclosure:
Dr. Moss has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with legal firms.

4:06 PM 004 Gene Therapy for LHON : Low and Medium Dose Results John Guy, MD
Disclosure:
Dr. Guy has nothing to disclose.

4:18 PM 005 Intravitreal rAAV2/2-ND4 (GS010): A gene therapy for vision loss in Leber′s Hereditary Optic Neuropathy (LHON) caused by the G11778A ND4 mitochondrial mutation Scott Uretsky, MD
Disclosure:
Dr. Uretsky has received personal compensation for activities with GenSight Biologics as an employee. Dr. Uretsky holds stock and/or stock options in GenSight Biologics.

4:30 PM 006 Jun and Ddit3 (CHOP) deficiency provides additive protection for retinal ganglion cell death after optic nerve injury Stephanie Syc
Disclosure:
Dr. Syc has nothing to disclose.

4:42 PM 007 Does the Combination of Acute Hearing Loss and Vertigo Increase Stroke Risk? Tzu-Pu Chang
Disclosure:
Dr. Chang has nothing to disclose.

4:54 PM 008 Visual Fixation Instability for Evaluating Multiple Sclerosis Using OCT-Based Quantification of Retinal Movements Robert Mallery, MD
Disclosure:
Dr. Mallery has nothing to disclose.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C3 Emergency Room Neuro-ophthalmology Heather Moss MD, PhD, FAAN
1:30 PM-3:30 PM
C18 Pediatric Neuro-ophthalmology Update Christopher Glisson DO

Sunday April 22, 2018

7:00 AM-9:00 AM
C25 Neuro-ophthalmology I: Visual Loss, Optic Neuropathies, and Papilledema Nancy Newman MD, FAAN
1:00 PM-3:00 PM
C43 Neuro-ophthalmology II: Optic Neuritis, Visual Fields, and Anisocoria Nancy Newman MD, FAAN
3:30 PM-5:30 PM
C56 Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus Nancy Newman MD, FAAN

Monday April 23, 2018

7:00 AM-9:00 AM
C60 Neuro-ophthalmology: Overview and Update Nancy Newman MD, FAAN
1:00 PM-5:30 PM
C82 Neuro-ophthalmology and Neurovestibular Exam Lab Skills Workshop John Pula MD, FAAN

Tuesday April 24, 2018

7:00 AM-9:00 AM
C102 Now You See It, Now You Know It: Pathognomonic Neuro-ophthalmology Examination Findings Wayne Cornblath MD, FAAN

Wednesday April 25, 2018

7:00 AM-9:00 AM
C132 Higher Cortical Visual Disorders: Case-based Review Sashank Prasad MD
1:00 PM-3:00 PM
C151 Nystagmus and Saccadic Intrusions Made Simple Janet Rucker MD
3:30 PM-5:30 PM
C166 Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia Janet Rucker MD

Thursday April 26, 2018

1:00 PM-3:00 PM
C190 Neuro-otology I: The Common Peripheral Vestibular Disorders Kevin Kerber MD
3:30 PM-5:30 PM
C204 Neuro-otology II: Diagnosis and Treatment of Nuanced Causes of Dizziness Kevin Kerber MD

MEMBER LOG IN

Forgot Password?